首页 > 最新文献

Clinics of surgery最新文献

英文 中文
Elevated STK1p After the Second-Cycle-Chemotherapy Associated with Failure Poor Survival in I-II Stage of NSCLCs- Three Cases Reports 第二周期化疗后STK1p升高与I-II期非小细胞肺癌的失败和低生存率相关——3例报告
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.61002
Zhenxin Wang, Guoqing Zhang, Jin Li, Hongbo Ma, Ji Zhou, E. He, S. Skog
Elevated STK1p After the Second-Cycle-Chemotherapy Associated with Failure Poor Survival in I-II Stage of NSCLCsThree Cases Reports Zhenxin Wang1, Guoqing Zhang2, Jin Li3, Hongbo Ma3, Ji Zhou3, Ellen He3* and Sven Skog3 1Department of Oncology, Affiliated Hospital of Suzhou University, Shizi Street 188, Gusu District, Suzhou, China 2Department of Oncology, Peking 301 Chinese PLA General Hospital, Fuxing Road 28, Haidian District, Beijing 100853, China 3Department of Medicine, Shenzhen Ellen-Sven Precision Medicine Institute, Shenzhen 518057, China
非小细胞肺癌I-II期二期化疗后STK1p升高与失败生存率低3例报告王振新1,张国清2,李瑾3,马洪波3,周吉3,何ellen 3*, Skog3 1苏州市姑苏区石子街188号苏州大学附属医院肿瘤科2北京301解放军总医院肿瘤科,海淀区复兴路28号北京301解放军总医院,100853深圳市艾伦斯文精密医学研究所,广东深圳518057
{"title":"Elevated STK1p After the Second-Cycle-Chemotherapy Associated with Failure Poor Survival in I-II Stage of NSCLCs- Three Cases Reports","authors":"Zhenxin Wang, Guoqing Zhang, Jin Li, Hongbo Ma, Ji Zhou, E. He, S. Skog","doi":"10.47829/cos.2021.61002","DOIUrl":"https://doi.org/10.47829/cos.2021.61002","url":null,"abstract":"Elevated STK1p After the Second-Cycle-Chemotherapy Associated with Failure Poor Survival in I-II Stage of NSCLCsThree Cases Reports Zhenxin Wang1, Guoqing Zhang2, Jin Li3, Hongbo Ma3, Ji Zhou3, Ellen He3* and Sven Skog3 1Department of Oncology, Affiliated Hospital of Suzhou University, Shizi Street 188, Gusu District, Suzhou, China 2Department of Oncology, Peking 301 Chinese PLA General Hospital, Fuxing Road 28, Haidian District, Beijing 100853, China 3Department of Medicine, Shenzhen Ellen-Sven Precision Medicine Institute, Shenzhen 518057, China","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"10 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77446393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Exploration of The Mechanism of Qianliexin Capsule Against Chronic Nonbacterial Prostatitis Using Metabolomicsv 代谢组学研究前列心胶囊治疗慢性非细菌性前列腺炎的作用机制
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.6501
Z. L., Z. Y., Z. M., Zhao J, Y. X, L. Y., Zhang J, Chen Y, Shang Y, Wang P, Yang Z, Zhou L, Chi Y, M. Z, L. J
Exploration of The Mechanism of Qianliexin Capsule Against Chronic Nonbacterial Prostatitis Using Metabolomicsv Zang L1, Zhang Y2, Zhang M1, Zhao J1, Yang X1, Li Y1, Zhang J1, Chen Y1, Shang Y1, Wang P1, Yang Z1, Zhou L1, Chi Y1, Meng Z2* and Lu J1* 1Institute of Life science and Bio-pharmaceuticals, Pharmaceutical College, Shenyang Pharmaceutical University, China 2Institute of traditional Chinese Medicine, Shandong Hongjitang Pharmaceutical Group Co., Ltd., China
利用代谢组学研究前列心胶囊治疗慢性非细菌性前列腺炎的作用机制[j]臧1 1,张1 1,张1 1,赵1 1,杨1 1,李1,张1,陈1,尚1,王1 1,杨1,周1 1,迟1,孟2*,陆1* 1 .沈阳药科大学药学院生命科学与生物制药研究所,中国2 .山东宏济堂医药集团有限公司中药研究所
{"title":"Exploration of The Mechanism of Qianliexin Capsule Against Chronic Nonbacterial Prostatitis Using Metabolomicsv","authors":"Z. L., Z. Y., Z. M., Zhao J, Y. X, L. Y., Zhang J, Chen Y, Shang Y, Wang P, Yang Z, Zhou L, Chi Y, M. Z, L. J","doi":"10.47829/cos.2021.6501","DOIUrl":"https://doi.org/10.47829/cos.2021.6501","url":null,"abstract":"Exploration of The Mechanism of Qianliexin Capsule Against Chronic Nonbacterial Prostatitis Using Metabolomicsv Zang L1, Zhang Y2, Zhang M1, Zhao J1, Yang X1, Li Y1, Zhang J1, Chen Y1, Shang Y1, Wang P1, Yang Z1, Zhou L1, Chi Y1, Meng Z2* and Lu J1* 1Institute of Life science and Bio-pharmaceuticals, Pharmaceutical College, Shenyang Pharmaceutical University, China 2Institute of traditional Chinese Medicine, Shandong Hongjitang Pharmaceutical Group Co., Ltd., China","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77825888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency Medical Care and Management of Sports Injuries On the Football Court 足球场上运动损伤的急救与处理
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.4604
Lenjani B, R. P, Shabani G, D. A, Pelaj B, D. A, Sylaj R, Mulaj Ev, Lenjani D
{"title":"Emergency Medical Care and Management of Sports Injuries On the Football Court","authors":"Lenjani B, R. P, Shabani G, D. A, Pelaj B, D. A, Sylaj R, Mulaj Ev, Lenjani D","doi":"10.47829/cos.2021.4604","DOIUrl":"https://doi.org/10.47829/cos.2021.4604","url":null,"abstract":"","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"20 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82409756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Importance of Micrornas in Human Cancer Development: A Molecular Analytical Approach 微rna在人类癌症发展中的重要性:一种分子分析方法
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.6401
A. Fe, Gouda Mm, Ahmed Nc
Importance of Micrornas in Human Cancer Development: A Molecular Analytical Approach Ahmed FE1*, Gouda MM2,3 and Ahmed NC4 1,4GEM Tox Labs, Institute for Research in Biotechnology, 2905 South Memorial Drive, Greenville, NC 27834, USA 2,3Egypt National Research Center, Giza, Dokki, Cairo, Egypt, and College of Biosystems Engineering and Food Science, Zhejang University, 866 Yuhangtang, Hangzhou, 310058, China
Micrornas在人类癌症发展中的重要性:分子分析方法Ahmed FE1*, Gouda MM2,3和Ahmed NC4 1,4GEM Tox实验室,生物技术研究所,2905 South Memorial Drive, Greenville, NC 27834, USA 2,3埃及国家研究中心,埃及开罗吉萨,Dokki,埃及,浙江大学生物系统工程与食品科学学院,杭州余杭汤866,中国,310058
{"title":"Importance of Micrornas in Human Cancer Development: A Molecular Analytical Approach","authors":"A. Fe, Gouda Mm, Ahmed Nc","doi":"10.47829/cos.2021.6401","DOIUrl":"https://doi.org/10.47829/cos.2021.6401","url":null,"abstract":"Importance of Micrornas in Human Cancer Development: A Molecular Analytical Approach Ahmed FE1*, Gouda MM2,3 and Ahmed NC4 1,4GEM Tox Labs, Institute for Research in Biotechnology, 2905 South Memorial Drive, Greenville, NC 27834, USA 2,3Egypt National Research Center, Giza, Dokki, Cairo, Egypt, and College of Biosystems Engineering and Food Science, Zhejang University, 866 Yuhangtang, Hangzhou, 310058, China","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"97 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85538512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Communicating Anti-Malaria Drugs Amongst ‘A’ Group Gynotype Groups in South East Nigeria 在尼日利亚东南部的“A”群中传播抗疟疾药物
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.61105
Njoku C, Ngene AH, Udeh K, Chukwuma UA, Oyeduntan EA
The effective communication of risks involved in anti-malaria dosage information dissemination is fundamental in health education and advocacies. Although there is no known pattern of communication perspective regarding numerous health risks involved in self-medication of anti-malaria drugs in Nigeria setting especially as more than half of the entire population relay on self-medication because of poor healthcare system. This paper reviews and evaluates the relative merits of two approaches to health risk communication of anti-malaria drugs on patients in Nigeria. One approach relies on the presentation of numerical information regarding the probability of a health problem occurring annually despite the claim of malaria eradication, whereas the other relies on the presentation of information about the antecedents and consequences of a health problem. Because people have considerable difficulty understanding and using quantitative information on the anti-malaria leaflets, the effectiveness of interventions that rely solely on numerical probability information has been limited. Interventions that provide people with a broader informational context to think about a health problem have had greater success systematically influencing perceptions of personal risk but have several important limitations. However, before any final conclusions can be drawn regarding the relative merits of different health risk communication strategies, investigators must agree on the specific criteria that should be used to identify an effective intervention. The finding pre-supposes a recurring pattern of approach to health risk information based on the peculiarity of recent interventions in the health sector
有效宣传抗疟疾剂量信息传播所涉及的风险是健康教育和宣传的基础。尽管在尼日利亚,由于医疗保健系统落后,超过一半的人口依赖于自我药疗,但对于抗疟疾药物自我药疗所涉及的众多健康风险,目前还没有已知的沟通模式。本文综述和评价了尼日利亚两种抗疟疾药物健康风险通报方法的相对优点。一种方法依赖于提供关于尽管声称消灭疟疾但每年发生健康问题的概率的数字信息,而另一种方法依赖于提供关于健康问题的前因后果的信息。由于人们很难理解和使用抗疟疾传单上的定量信息,因此仅依靠数字概率信息的干预措施的有效性受到限制。为人们提供更广泛的信息背景来思考健康问题的干预措施在系统地影响个人风险认知方面取得了更大的成功,但也有一些重要的局限性。然而,在就不同健康风险沟通策略的相对优点得出任何最终结论之前,调查人员必须就应用于确定有效干预措施的具体标准达成一致。根据最近卫生部门干预措施的特殊性,这一发现预先假定了一种反复出现的健康风险信息处理模式
{"title":"Communicating Anti-Malaria Drugs Amongst ‘A’ Group Gynotype Groups in South East Nigeria","authors":"Njoku C, Ngene AH, Udeh K, Chukwuma UA, Oyeduntan EA","doi":"10.47829/cos.2021.61105","DOIUrl":"https://doi.org/10.47829/cos.2021.61105","url":null,"abstract":"The effective communication of risks involved in anti-malaria dosage information dissemination is fundamental in health education and advocacies. Although there is no known pattern of communication perspective regarding numerous health risks involved in self-medication of anti-malaria drugs in Nigeria setting especially as more than half of the entire population relay on self-medication because of poor healthcare system. This paper reviews and evaluates the relative merits of two approaches to health risk communication of anti-malaria drugs on patients in Nigeria. One approach relies on the presentation of numerical information regarding the probability of a health problem occurring annually despite the claim of malaria eradication, whereas the other relies on the presentation of information about the antecedents and consequences of a health problem. Because people have considerable difficulty understanding and using quantitative information on the anti-malaria leaflets, the effectiveness of interventions that rely solely on numerical probability information has been limited. Interventions that provide people with a broader informational context to think about a health problem have had greater success systematically influencing perceptions of personal risk but have several important limitations. However, before any final conclusions can be drawn regarding the relative merits of different health risk communication strategies, investigators must agree on the specific criteria that should be used to identify an effective intervention. The finding pre-supposes a recurring pattern of approach to health risk information based on the peculiarity of recent interventions in the health sector","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88736163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report: COVID Vaccine-Induced Immune Thrombocytopenia COVID疫苗致免疫性血小板减少症1例报告
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.51201
Lwin Zaw Thant, N. Phyu
{"title":"A Case Report: COVID Vaccine-Induced Immune Thrombocytopenia","authors":"Lwin Zaw Thant, N. Phyu","doi":"10.47829/cos.2021.51201","DOIUrl":"https://doi.org/10.47829/cos.2021.51201","url":null,"abstract":"","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"57 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74352961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The New Scientific Foundation of Fluid Therapy in Shock Management 休克治疗液体疗法的新科学基础
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.61301
Ahmed Nasr M Ghanem
Intravenous fluids are commonly prescribed, but uncertainty remains about how to assess when fluids are required and how much to give [1]. Two recent guidelines have acknowledged a limited evidence base to guide fluid assessment. A recommended means to assess hypovolaemia includes assessment of fluid responsiveness. Fluid responsiveness is a rise in stroke volume following an increase in preload, achieved using a fluid challenge or a passive leg raise. However, the means of defining fluid responsiveness and its ability to identify patients who would benefit from fluid resuscitation is currently unclear.
静脉输液通常是处方,但如何评估何时需要输液以及给多少仍不确定[1]。最近的两项指南承认,指导流体评估的证据基础有限。评估低血容量的推荐方法包括评估液体反应性。液体反应是指预负荷增加后冲程量的增加,通过液体刺激或被动抬腿来实现。然而,定义液体反应的方法及其识别将受益于液体复苏的患者的能力目前尚不清楚。
{"title":"The New Scientific Foundation of Fluid Therapy in Shock Management","authors":"Ahmed Nasr M Ghanem","doi":"10.47829/cos.2021.61301","DOIUrl":"https://doi.org/10.47829/cos.2021.61301","url":null,"abstract":"Intravenous fluids are commonly prescribed, but uncertainty remains about how to assess when fluids are required and how much to give [1]. Two recent guidelines have acknowledged a limited evidence base to guide fluid assessment. A recommended means to assess hypovolaemia includes assessment of fluid responsiveness. Fluid responsiveness is a rise in stroke volume following an increase in preload, achieved using a fluid challenge or a passive leg raise. However, the means of defining fluid responsiveness and its ability to identify patients who would benefit from fluid resuscitation is currently unclear.","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80781486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Combined Detection of Preoperative Neutrophil to Lymphocyte Ratio and Interleukin-6 as an Independent Prognostic Factor for Patients with Non-Metastatic Colorectal Cancer 术前中性粒细胞/淋巴细胞比和白细胞介素-6联合检测作为非转移性结直肠癌患者预后的独立因素
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.6203
Zhifeng Y, Yongjing L, Z. K, Xuejie D, S. R., Z. W
Combined Detection of Preoperative Neutrophil to Lymphocyte Ratio and Interleukin-6 as an Independent Prognostic Factor for Patients with Non-Metastatic Colorectal Cancer Zhifeng Y1, Yongjing L1, Zhang K1, Xuejie D2, Shikuo R3,* and Zhen W2* 1Department of Laboratory, Liaocheng Maternal and Child Health Hospital, Shandong, China 2Department of Gastroenterology, Leshan People’s Hospital, Sichuan, China 3Department of general surgery, Chengdu Second People’s Hospital, Chengdu, Sichuan, China
术前中性粒细胞/淋巴细胞比值及白细胞介素-6联合检测作为非转移性结直肠癌患者预后的独立因素志峰Y1、永晶L1、张K1、雪洁D2、世果R3、*、甄w2 * 1中国山东省聊城市妇幼保健医院检验科2中国四川省乐山市人民医院消化内科3中国四川省成都市第二人民医院普外科
{"title":"Combined Detection of Preoperative Neutrophil to Lymphocyte Ratio and Interleukin-6 as an Independent Prognostic Factor for Patients with Non-Metastatic Colorectal Cancer","authors":"Zhifeng Y, Yongjing L, Z. K, Xuejie D, S. R., Z. W","doi":"10.47829/cos.2021.6203","DOIUrl":"https://doi.org/10.47829/cos.2021.6203","url":null,"abstract":"Combined Detection of Preoperative Neutrophil to Lymphocyte Ratio and Interleukin-6 as an Independent Prognostic Factor for Patients with Non-Metastatic Colorectal Cancer Zhifeng Y1, Yongjing L1, Zhang K1, Xuejie D2, Shikuo R3,* and Zhen W2* 1Department of Laboratory, Liaocheng Maternal and Child Health Hospital, Shandong, China 2Department of Gastroenterology, Leshan People’s Hospital, Sichuan, China 3Department of general surgery, Chengdu Second People’s Hospital, Chengdu, Sichuan, China","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"110 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85482628","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Finite Solvability for Quasi-Eisenstein Matrices 拟爱森斯坦矩阵的有限可解性
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.6702
P. F., De Ninno G, Fanelli D, Rospo Dio
*Corresponding author: Piazza Francesco, University of Orléans, Chéteau de la Source, Center for Molecular Biophysics (CBM), CNRS-UPR 4301, Rue C. Sadron, Orléans 45071, France, E-mail: francesco.piazza@cnrs-orleans.fr Received: 20 Sep 2021 Accepted: 30 Sep 2021 Published: 05 Oct 2021 Copyright: ©2021 Piazza F, This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.
*通讯作者:Piazza Francesco, University of orlsamans, ch de la Source, centre for Molecular Biophysics (CBM), CNRS-UPR 4301, Rue C. Sadron, orlsamans 45071, France, E-mail: francesco.piazza@cnrs-orleans.fr收稿日期:2021年9月20日接收日期:2021年9月30日发布日期:2021年10月05日版权所有:©2021 Piazza F,这是一篇根据知识共享署名许可条款发布的开放获取文章,该许可允许不受限制地使用,分发和非商业地构建您的作品。
{"title":"Finite Solvability for Quasi-Eisenstein Matrices","authors":"P. F., De Ninno G, Fanelli D, Rospo Dio","doi":"10.47829/cos.2021.6702","DOIUrl":"https://doi.org/10.47829/cos.2021.6702","url":null,"abstract":"*Corresponding author: Piazza Francesco, University of Orléans, Chéteau de la Source, Center for Molecular Biophysics (CBM), CNRS-UPR 4301, Rue C. Sadron, Orléans 45071, France, E-mail: francesco.piazza@cnrs-orleans.fr Received: 20 Sep 2021 Accepted: 30 Sep 2021 Published: 05 Oct 2021 Copyright: ©2021 Piazza F, This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72500795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laparoscopic Hepatectomy Reduces the Incidence of Postoperative Hypoalbuminemia: A Propensity Score Matching Analysis with Open Hepatectomy 腹腔镜肝切除术降低术后低白蛋白血症的发生率:与开放式肝切除术的倾向评分匹配分析
Pub Date : 2021-01-01 DOI: 10.47829/cos.2021.61001
Qinghua He, Qifan Zhang, Jian-ping Qian, Sheng Yu, Leyi Liao, Qingping Li, P. Huang, Hanbiao Liang, Z. Han, Qingyan Li, Xianbin Li, Yiran Wei, Bili Zhu, Jie Zhou, Liu Chuanjiang, Kai Wang
Background: This study investigated the incidence of post-hepatectomy hypoalbuminemia and the necessity of Intravenous Albumin (ALB) supplement for hypoalbuminemia after Laparoscopic Hepatectomy (LH). Methods: Nine hundred and eighty patients with Open Hepatectomy (OH) and 198 patients with LH were matched on the propensity score by 2:1. The incidences of postoperative hypoalbuminemia and the usage of ALB injection on different Postoperative Days (POD) were compared. Preventive and risk factors of hypoalbuminemia were screened by logistic regression. Receiver Operator Characteristic (ROC) curve and nomogram were established to predict postoperative hypoalbuminemia. Result: 175 patients of LH and 296 patients of OH were matched. The usage of ALB injection was significantly lower in the LH group than those in the OH group (60.0 vs. 75.3%, P=0.000; 6.71 ± 6.99 vs. 8.62 ± 7.18 g, P=0.005). The incidences of postoperative hypoalbuminemia in the LH group were significantly lower than those in the OH group (62.3 vs. 78.4% (P=0.000) on POD 1, 51.4 vs. 71.6% (P=0.000) on POD 3, 37.1 vs. 51.4% (P=0.003) on POD 5, and 27.4 vs. 39.9% (P=0.006) on POD 7). Preoperative serum ALB level and Serum Alanine Aminotransferase (ALT) level was identified as independent protective and risk factor of hypoalbuminemia after LH, respectively. Preoperative serum ALB level below 42.95 g/L and serum ALT level above 28.50 U/L were identified as the reliable cut-off value to predict postoperative hypoalbuminemia after LH. A nomogram for predicting the probability of hypoalbuminemia after LH was established. Conclusion: LH with a reduced intravenous ALB supplement was still associated with a lower incidence of postoperative hypoalbuminemia.
背景:本研究探讨腹腔镜肝切除术(LH)术后低白蛋白血症的发生率及静脉补充白蛋白(ALB)的必要性。方法:90例开放式肝切除术(OH)患者和198例LH患者的倾向性评分按2:1匹配。比较两组患者术后不同天数(POD)低白蛋白血症发生率及ALB注射液使用情况。采用logistic回归方法筛选低白蛋白血症的预防和危险因素。建立受试者操作特征(ROC)曲线和nomogram预测术后低白蛋白血症。结果:LH 175例,OH 296例。LH组ALB注射液使用率明显低于OH组(60.0 vs. 75.3%, P=0.000;(6.71±6.99 g vs. 8.62±7.18 g, P=0.005)。LH组术后低白蛋白血症发生率明显低于OH组(POD 1组62.3比78.4% (P=0.000), POD 3组51.4比71.6% (P=0.000), POD 5组37.1比51.4% (P=0.003), POD 7组27.4比39.9% (P=0.006))。术前血清ALB水平和血清丙氨酸转氨酶(ALT)水平分别被确定为LH术后低白蛋白血症的独立保护因素和危险因素。术前血清ALB水平低于42.95 g/L,血清ALT水平高于28.50 U/L被确定为预测LH术后低白蛋白血症的可靠临界值。建立了预测LH后低白蛋白血症概率的nomogram。结论:LH与静脉白蛋白补充减少仍然与术后低白蛋白血症发生率较低相关。
{"title":"Laparoscopic Hepatectomy Reduces the Incidence of Postoperative Hypoalbuminemia: A Propensity Score Matching Analysis with Open Hepatectomy","authors":"Qinghua He, Qifan Zhang, Jian-ping Qian, Sheng Yu, Leyi Liao, Qingping Li, P. Huang, Hanbiao Liang, Z. Han, Qingyan Li, Xianbin Li, Yiran Wei, Bili Zhu, Jie Zhou, Liu Chuanjiang, Kai Wang","doi":"10.47829/cos.2021.61001","DOIUrl":"https://doi.org/10.47829/cos.2021.61001","url":null,"abstract":"Background: This study investigated the incidence of post-hepatectomy hypoalbuminemia and the necessity of Intravenous Albumin (ALB) supplement for hypoalbuminemia after Laparoscopic Hepatectomy (LH). Methods: Nine hundred and eighty patients with Open Hepatectomy (OH) and 198 patients with LH were matched on the propensity score by 2:1. The incidences of postoperative hypoalbuminemia and the usage of ALB injection on different Postoperative Days (POD) were compared. Preventive and risk factors of hypoalbuminemia were screened by logistic regression. Receiver Operator Characteristic (ROC) curve and nomogram were established to predict postoperative hypoalbuminemia. Result: 175 patients of LH and 296 patients of OH were matched. The usage of ALB injection was significantly lower in the LH group than those in the OH group (60.0 vs. 75.3%, P=0.000; 6.71 ± 6.99 vs. 8.62 ± 7.18 g, P=0.005). The incidences of postoperative hypoalbuminemia in the LH group were significantly lower than those in the OH group (62.3 vs. 78.4% (P=0.000) on POD 1, 51.4 vs. 71.6% (P=0.000) on POD 3, 37.1 vs. 51.4% (P=0.003) on POD 5, and 27.4 vs. 39.9% (P=0.006) on POD 7). Preoperative serum ALB level and Serum Alanine Aminotransferase (ALT) level was identified as independent protective and risk factor of hypoalbuminemia after LH, respectively. Preoperative serum ALB level below 42.95 g/L and serum ALT level above 28.50 U/L were identified as the reliable cut-off value to predict postoperative hypoalbuminemia after LH. A nomogram for predicting the probability of hypoalbuminemia after LH was established. Conclusion: LH with a reduced intravenous ALB supplement was still associated with a lower incidence of postoperative hypoalbuminemia.","PeriodicalId":92767,"journal":{"name":"Clinics of surgery","volume":"991 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77133279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinics of surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1